by Pierre Roux | Sep 1, 2013 | Press Releases
NeuroCog Trials, Inc. announces that a new method has been established for reviewing administration procedures and data collection for the Alzheimer’s Disease Assessment Scale (ADAS-Cog). This method will be utilized by a large pharmaceutical company for a new... by Pierre Roux | Aug 27, 2013 | Press Releases
NeuroCog Trials, Inc. announces that it has grown to 100 full time employees. Richard Keefe, Ph.D., Founder and CEO of NeuroCog Trials, said, “The mission of NeuroCog has always been to provide high quality cognitive methodologies for our sponsors and the patients... by Pierre Roux | Aug 27, 2013 | Press Releases
NeuroCog Trials, Inc. announces that they have begun providing support for the cognitive outcomes of a new global Phase 3 clinical trial. This study investigates a genetic-based biomarker Trial Press Release: NeuroCog Trials, Inc. announces support for the cognitive... by Pierre Roux | Feb 1, 2013 | Press Releases
NeuroCog Trials, Inc. announces that they have begun work supporting a pharmaceutical company clinical trial to assess cognition in patients with chronic kidney disease. The trial will examine the effects of active drug treatment versus placebo on standard... by Pierre Roux | Jan 15, 2013 | Press Releases
NeuroCog Trials, Inc. announces that they have begun work supporting a pharmaceutical company clinical trial to assess cognition in adult patients with phenylketonuria (PKU). The trial will examine the effects of active drug treatment versus placebo on tests selected...